Polyrizon ltd. files annual report on form 20-f for the fiscal year ended december 31, 2024

Raanana, israel, march 11, 2025 (globe newswire) -- polyrizon ltd. (nasdaq: plrz) (the "company" or "polyrizon"), a development stage biotech company specializing in the development of innovative intranasal hydrogels, today announced that it has filed its annual report on form 20-f for the fiscal year ended december 31, 2024, with the u.s. securities and exchange commission (the "sec").
PLRZ Ratings Summary
PLRZ Quant Ranking